Zobrazeno 1 - 10
of 53
pro vyhledávání: '"van der Maazen RW"'
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. 232:591-598
• Background: The natural course of the visual acuity of age-related subfoveal choroidal neovascularisation (CNV) membranes is poor. Laser photocoagulation of subfoveal CNV is recommended if the patient is willing to accept a large decrease in visu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20323752d533dd70a920c97a638d6d27
https://doi.org/10.1007/bf00193119
https://doi.org/10.1007/bf00193119
Autor:
van der Maazen RW, Raemaekers JM
Publikováno v:
Current Opinion in Oncology; Nov2006, Vol. 18 Issue 6, p660-666, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Heutte N (AUTHOR), Flechtner HH (AUTHOR), Mounier N (AUTHOR), Mellink WA (AUTHOR), Meerwaldt JH (AUTHOR), Eghbali H (AUTHOR), van't Veer MB (AUTHOR), Noordijk EM (AUTHOR), Kluin-Nelemans JC (AUTHOR), Lampka E (AUTHOR), Thomas J (AUTHOR), Lugtenburg PJ (AUTHOR), Viterbo L (AUTHOR), Carde P (AUTHOR), Hagenbeek A (AUTHOR), van der Maazen RW (AUTHOR), Smit WG (AUTHOR), Brice P (AUTHOR), van Marwijk Kooy M (AUTHOR), Baars JW (AUTHOR)
Publikováno v:
Lancet Oncology. Dec2009, Vol. 10 Issue 12, p1160-1170. 11p.
Autor:
Nijdam A; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Dekker N; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van 't Veer MB; Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands., Daniels LA; Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands., van der Maazen RW; Department of Radiotherapy, Radboud University Medical Centre, Nijmegen, the Netherlands., Janus CPM; Department of Radiotherapy, Erasmus Medical Centre, Rotterdam, the Netherlands., de Weijer RJ; Department of Haematology, University Medical Centre Utrecht, Utrecht, the Netherlands., Zijlstra JM; Department of Haematology, Amsterdam UMC, Location VU Medical Centre, Amsterdam, the Netherlands., Stedema FG; Department of Haematology, University Medical Centre Groningen, Groningen, the Netherlands., Ta BD; Department of Radiotherapy, MAASTRO Clinic, Maastricht, the Netherlands., Posthuma EFM; Department of Haematology, Reinier de Graaf Group, Delft, the Netherlands., Manenschijn A; Department of Haematology, Isala, Zwolle, the Netherlands., Dielwart MFH; Department of Radiotherapy, Zeeuws Radiotherapy Institute, Vlissingen, the Netherlands., Bilgin YM; Department of Haematology, Adrz Hospital, Goes, the Netherlands., van den Heuvel MJ; Department of Haematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Boersma RS; Department of Haematology, Amphia Hospital, Breda, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Raemaekers JMM; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.
Publikováno v:
British journal of haematology [Br J Haematol] 2019 Aug; Vol. 186 (4), pp. e103-e108. Date of Electronic Publication: 2019 May 15.
Autor:
van Eggermond AM; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Schaapveld M; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands., Janus CP; Department of Radiation Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands., de Boer JP; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., Krol AD; Division of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, The Netherlands., Zijlstra JM; Department of Hematology, VU University Medical Center, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands., van der Maazen RW; Department of Radiation Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525 GA, The Netherlands., Kremer LC; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Meibergdreef 9, Amsterdam-Zuidoost 1105 AZ, The Netherlands., van Leerdam ME; Department of Gastroenterology and Hepatology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Louwman MW; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands., Visser O; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands., De Bruin ML; Department of Pharmacy, Faculty of Health and Medical Science (CORS), University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark., Aleman BM; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands., van Leeuwen FE; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.
Publikováno v:
British journal of cancer [Br J Cancer] 2017 Jul 25; Vol. 117 (3), pp. 306-314. Date of Electronic Publication: 2017 Jun 20.
Autor:
Rigter LS; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Spaander MC; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Moons LM; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Bisseling TM; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., Aleman BM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Boer JP; Department of Hematology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Janus CP; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Petersen EJ; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Roesink JM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Raemaekers JM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Maazen RW; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Cats A; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Bleiker EM; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Carvalho B; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Jóźwiak K; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Te Riele H; Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands., Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leerdam ME; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. m.v.leerdam@nki.nl.
Publikováno v:
BMC cancer [BMC Cancer] 2017 Feb 07; Vol. 17 (1), pp. 112. Date of Electronic Publication: 2017 Feb 07.
Autor:
Schaapveld M; From the Departments of Epidemiology (M.S., A.M.E., I.M., I.M.K., F.E.L.), Radiation Oncology (B.M.P.A.), and Hematology (J.P.B.), Netherlands Cancer Institute, and the Department of Hematology, VU University Medical Center Amsterdam (J.M.Z.), Amsterdam, the Netherlands Comprehensive Cancer Organization (M.S., I.M., O.V., M.W.J.L.) and the Departments of Radiation Oncology (J.R.) and Hematology (E.J.P.), University Medical Center Utrecht, Utrecht, the Departments of Radiation Oncology (C.P.M.J.) and Hematology (P.J.L.), Erasmus Medical Center Cancer Institute, Rotterdam, the Department of Radiation Oncology, Leiden University Medical Center, Leiden (A.D.G.K.), the Department of Radiation Oncology, Radboud University Medical Center (R.W.M.M., P.M.P.P.), and the Department of Education and Science, Canisius-Wilhelmina Hospital (I.M.), Nijmegen, the Department of Hematology, Radboud University Medical Center, Nijmegen-Rijnstate, Arnhem (J.M.M.R.), the Departments of Hematology (G.W.I.) and Radiation Oncology (M.B.), University Medical Center Groningen, Groningen, the Department of Radiation Oncology, Dr. Bernard Verbeeten Institute, Tilburg (P.M.P.P.), and the Department of Radiotherapy, Catharina Hospital, Eindhoven (M.L.L.) - all in the Netherlands., Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE
Publikováno v:
The New England journal of medicine [N Engl J Med] 2015 Dec 24; Vol. 373 (26), pp. 2499-511.
Autor:
Stienen JJ; Scientific Institute for Quality of Healthcare (IQ healthcare), Radboud university medical center (Radboud umc), PO Box 9101, 6500 HB, Nijmegen, the Netherlands. JozetteStienen@gmail.com., Hermens RP; Scientific Institute for Quality of Healthcare (IQ healthcare), Radboud university medical center (Radboud umc), PO Box 9101, 6500 HB, Nijmegen, the Netherlands. Rosella.Hermens@Radboudumc.nl., Wennekes L; Scientific Institute for Quality of Healthcare (IQ healthcare), Radboud university medical center (Radboud umc), PO Box 9101, 6500 HB, Nijmegen, the Netherlands. Lianne.Wennekes@Radboudumc.nl., van de Schans SA; Netherlands Comprehensive Cancer Organisation, Department of Registry and Research, PO box 19079, 3501 DB, Utrecht, the Netherlands. sam_vd_schans@hotmail.com., van der Maazen RW; Department of Radiotherapy, Radboud university medical center, Nijmegen, the Netherlands. Richard.vanderMaazen@Radboudumc.nl., Dekker HM; Department of Radiology, Radboud university medical center, Nijmegen, the Netherlands. Heleen.Dekker@Radboudumc.nl., Liefers J; Scientific Institute for Quality of Healthcare (IQ healthcare), Radboud university medical center (Radboud umc), PO Box 9101, 6500 HB, Nijmegen, the Netherlands. Janine.Liefers@Radboudumc.nl., van Krieken JH; Department of Pathology, Radboud university medical center, Nijmegen, the Netherlands. Han.vanKrieken@Radboudumc.nl., Blijlevens NM; Department of Hematology, Radboud university medical center, Nijmegen, The Netherlands. Nicole.Blijlevens@Radboudumc.nl., Ottevanger PB; Department of Medical Oncology, Radboud university medical center, Nijmegen, the Netherlands. Nelleke.Ottevanger@Radboudumc.nl.
Publikováno v:
BMC cancer [BMC Cancer] 2015 Aug 08; Vol. 15, pp. 578. Date of Electronic Publication: 2015 Aug 08.
Autor:
Stienen JJ; Department of IQ Healthcare, Radboud University Medical Center, Radboud Institute for Health Sciences, PO box 9101, 6500 HB, Nijmegen, The Netherlands, JozetteStienen@gmail.com., Ottevanger PB, Wennekes L, van de Schans SA, Dekker HM, van der Maazen RW, van Krieken JH, Blijlevens NM, Hermens RP
Publikováno v:
Annals of hematology [Ann Hematol] 2015 Jul; Vol. 94 (7), pp. 1195-203. Date of Electronic Publication: 2015 Mar 15.